# Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis

> **NCT01157819** · PHASE2 · COMPLETED · sponsor: **Otic Pharma** · enrollment: 70 (estimated)

## Conditions studied

- Otitis Externa
- Otorhinolaryngologic Diseases
- Ear Diseases
- Otitis

## Interventions

- **DRUG:** 0.3% Ciprofloxacin Ear Drops
- **DRUG:** FoamOtic Cipro

## Key facts

- **NCT ID:** NCT01157819
- **Lead sponsor:** Otic Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-11
- **Final completion:** 2010-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157819, "Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01157819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*